It is a third-party organization specializing in genetic testing of medication for mental illnesses, with national accreditation, are more famous in the country, and their ability to enhance the capacity of precision medical services for psychiatric illnesses is also the 2020 Shanghai Service Industry Development Guiding Funding Support Project, which is officially recognized.

In today's society, mental illnesses like depression, the incidence is still relatively high, in addition to genetic factors, high-pressure environment is also a major factor leading to mental illness. Regardless of what factors lead to the onset of mental illness, for the treatment of mental illness, individualized treatment should be achieved in order to achieve the best therapeutic effect and reduce the pain of patients. If you still use the traditional treatment program, not only can not be completely cured, and will even aggravate the condition.

The genetic test can clarify the drug response and adverse drug reaction information of each individual, and then assist doctors to clinically formulate the medication plan, thus improving the effectiveness and safety of psychiatric drugs, and helping patients to realize precise treatment.

In many domestic medical conferences, especially those related to psychiatric diseases, the value of pharmacogenomics will be mentioned and affirmed when precision treatment is mentioned, such as in the 26th International Forum on Psychosomatic Medicine of the Chinese Medical Association held on October 17, 2020, the positive effect of this genetic test on individualized treatment was highly recognized by experts attending the conference. The positive effect of this genetic test on individualized treatment was highly recognized by the experts attending the meeting.